Clinical Trials on Immediate Type Hypersensitivity in Canada

Total 5025 results

Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Withdrawn

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Ragweed MATA MPL

Type I Hypersensitivity

Canada, United States
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Grass MATA MPL

Type I Hypersensitivity

United States, Canada, United Kingdom, Austria
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

Hypersensitivity, Immediate

Canada
Hamilton Health Sciences Corporation
AllerGen NCE Inc.; Food Allergy Initiative

Unknown

Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut

Peanut Hypersensitivity

Canada
The Hospital for Sick Children

Active, not recruiting

Low Dose Multi-OIT for Food Allergy (LoMo) (LoMO)

Food Allergy

Canada
McMaster University
AllerGen NCE Inc.

Unknown

Canadian Peanut Thresholds Study

Peanut Allergy

Canada
Hamilton Health Sciences Corporation
McMaster University; AllerGen NCE Inc.

Completed

Peanut Allergy Oral Immunotherapy Desensitization

Peanut Allergy

Canada
Philippe Bégin

Active, not recruiting

Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy (ATARI)

Peanut Allergy

Canada
McGill University Health Centre/Research Institute...

Active, not recruiting

Milk Desensitization in Children

Cow Milk Allergy

Canada
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); AAAAI Foundation

Recruiting

Thresholds In Food Allergy evaluaTion And predictioN (TITAN)

Food Allergy | Tree Nut Allergy

Canada
Gordon Sussman Clinical Research
Mast Cell Pharmaceuticals Inc.

Unknown

Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization

Peanut Allergies in Children

Canada
McGill University Health Centre/Research Institute...
Julia Upton, Hospital for Sick Children, University of Toronto

Active, not recruiting

Peanut and Tree Nut Desensitization

Peanut Allergy | Tree Nut Allergy

Canada
Austin Health

Completed

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge (PALACE)

Hypersensitivity, Immediate | Hypersensitivity, Delayed | Hypersensitivity Response

United States, Australia, Canada
McGill University Health Centre/Research Institute...
The Hospital for Sick Children

Recruiting

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety (IMPROVES)

Egg Allergy | Peanut Allergy | Milk Allergy, Cow's

Canada
Aldeyra Therapeutics, Inc.

Completed

A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber

Conjunctivitis, Allergic

Canada
Eleven Biotherapeutics

Completed

A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)

Allergic Conjunctivitis

Canada
Laval University

Completed

Role of Airway Hyperresponsiveness on Performance in Elite Swimmers.

Asthma

Canada
Aldeyra Therapeutics, Inc.

Completed

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

Allergic Conjunctivitis

Canada
Michael Marchand, MD
Université de Montréal

Recruiting

Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

Conjunctivitis, Allergic | Conjunctivitis, Vernal

Canada
Aldeyra Therapeutics, Inc.

Completed

The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

Allergic Conjunctivitis

Canada
ALK-Abelló A/S
Inflamax Research Incorporated

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Allergic Rhinoconjunctivitis

Canada
University of Saskatchewan

Completed

Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway Hyperresponsiveness

Airway Hyper Responsiveness

Canada
Anergis
Inflamax Research Incorporated

Completed

Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC

Allergic Rhino-Conjunctivitis

Canada
Allergy Therapeutics

Completed

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
Allergy Therapeutics

Terminated

Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
Innovaderm Research Inc.

Completed

Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

Delayed Type Hypersensitivity

Canada
HAL Allergy

Completed

HAL-MPE1 Safety and Tolerability Study

Peanut Allergy

United States, Canada
University of Saskatchewan
Royal University Hospital Foundation

Completed

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Asthma

Canada
Laval University

Unknown

Airway Dysfunction and Remodelling in Athletes Following Swimming Training in Chlorinated Pools (proto nage)

Asthma | Airway Hyperresponsiveness

Canada
McGill University Health Centre/Research Institute...

Recruiting

Patient Perspective on Climate Impact of Inhalers

Asthma

Canada
Université de Sherbrooke
Fonds de la Recherche en Santé du Québec; BioMérieux; Réseau de Recherche en... and other collaborators

Recruiting

Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA)

Asthma

Canada
McMaster University

Recruiting

Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma

Asthma

Canada
University of Calgary

Recruiting

Phenotyping Disease Severity in Asthma

Asthma

Canada
GlaxoSmithKline

Completed

Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec

Asthma

Canada
Ottawa Hospital Research Institute

Completed

Strategies to Improve Asthma and Treatment of Asthma in Canadians

Asthma

Canada
Children's Hospital of Eastern Ontario
CHAMO Innovation Fund

Completed

The Impact of Implementing a Nursing-driven Clinical Pathway for Inpatient Management of Children With Asthma (NAP)

Asthma

Canada
McGill University
Canadian Institutes of Health Research (CIHR)

Completed

Computer-Based Decision Support in Managing Asthma in Primary Care

Asthma

Canada
Laval University
CHU de Quebec-Universite Laval; AllerGen NCE Inc.

Completed

Evaluation of Decisional Conflict and Needs Assessment in Asthma Management

Asthma

Canada
Hamilton Health Sciences Corporation

Completed

Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics

Asthma

Canada
Hamilton Health Sciences Corporation
Takeda; Kolding Sygehus

Completed

Effect of Ciclesonide on Exercise Induced Bronchoconstriction

Asthma

Canada
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Peanut Allergy

United States, Canada
University of Saskatchewan

Completed

Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

Asthma

Canada

3

Subscribe